The influence of prior abiraterone treatment on the clinical activity of docetaxel in men with metastatic castration-resistant prostate cancer. [electronic resource]
Producer: 20151019Description: 646-52 p. digitalISSN:- 1873-7560
- Aged
- Androstenes -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bone Neoplasms -- secondary
- Cohort Studies
- Disease Progression
- Disease-Free Survival
- Docetaxel
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Drug Interactions
- Follow-Up Studies
- Humans
- Kaplan-Meier Estimate
- Lung Neoplasms -- secondary
- Male
- Middle Aged
- Multivariate Analysis
- Neoplasm Invasiveness -- pathology
- Neoplasm Staging
- Proportional Hazards Models
- Prostatic Neoplasms, Castration-Resistant -- drug therapy
- Retrospective Studies
- Risk Assessment
- Survival Rate
- Taxoids -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.